Product logins

Find logins to all Clarivate products below.


Pulmonology Devices | Market Insights | US | 2022

US pulmonology device market has been moderately impacted by the COVID-19 pandemic but will nevertheless grow strongly over the forecast period, fueled by bronchoscopy procedure volume growth, favorable demographic trends, and the adoption of premium-priced technologies, particularly in the bronchoscope market. However, a lack of product innovation and minimal procedure volume growth in some pulmonology device market segments will limit the growth of the overall pulmonology device market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for pulmonology devices in the US across a 11-year period.

Related Medtech Insights Reports

Report
Heart Valve Devices | Market Insights | Europe | 2022
The European heart valve device market has been negatively impacted by the global COVID-19 pandemic; however, in the longer term, the market will be driven by an aging population in this country…
Report
Urological Devices | Market Insights | Europe | 2022
The deferral or cancellation of nonessential procedures due to the COVID-19 pandemic negatively impacted the European urological device market in 2020; however, the market will show a strong…
Report
Peripheral Vascular Devices | Market Insights | US | 2022
Following the negative impact of the COVID-19 pandemic, the US market for PV devices will face new challenges brought about by reimbursement changes, while a large undiagnosed patient…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific | 2022
While the COVID-19 pandemic will have a negative but limited impact on the Asia Pacific transcatheter embolization and occlusion device market in the short term, the market will expand at a …
Report
Peripheral Vascular Devices | Market Insights | Latin America (Supplemental) | 2021
Following the negative impact of the COVID-19 pandemic, the US market for PV devices will face new challenges brought about by reimbursement changes, while a large undiagnosed patient…